Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vijay Manglam"'
Autor:
Bruce M. Hendry, Nina Stafford, Ahran D. Arnold, Arvind Sangwaiya, Vijay Manglam, Stuart D. Rosen, Jayantha Arnold
Publikováno v:
Pharmacology Research & Perspectives, Vol 8, Iss 4, Pp n/a-n/a (2020)
Abstract We propose a new hypothesis that the established drug pentoxifylline deserves attention as a potential repurposed therapeutic for COVID‐19. Pentoxifylline is an immunomodulator with anti‐inflammatory properties. It is a nonselective phos
Externí odkaz:
https://doaj.org/article/b357645a161247f29c91c2602e086d65
Autor:
Stuart D. Rosen, Ahran D. Arnold, Bruce M. Hendry, Jayantha Arnold, NIna Stafford, Arvind Sangwaiya, Vijay Manglam
We wish to highlight a new hypothesis, that the early phase of COVID-19 is characterised by non-cardiogenic pulmonary oedema (‘leaky lungs’). We hypothesize that COVID-19 complications in lungs might progress through the initial stages of ‘leak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6879eae806866476464f3b086224a735
https://doi.org/10.22541/au.159200650.00722246
https://doi.org/10.22541/au.159200650.00722246
Autor:
Stuart D. Rosen, Jayantha Arnold, Vijay Manglam, Ahran D. Arnold, NIna Stafford, Arvind Sangwaiya, Bruce M. Hendry
Publikováno v:
Pharmacology Research & Perspectives, Vol 8, Iss 4, Pp n/a-n/a (2020)
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives
We propose a new hypothesis that the established drug pentoxifylline deserves attention as a potential repurposed therapeutic for COVID‐19. Pentoxifylline is an immunomodulator with anti‐inflammatory properties. It is a nonselective phosphodieste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7083da0ec032aa246b8dbf08309efd3
https://doi.org/10.22541/au.159188547.77617510
https://doi.org/10.22541/au.159188547.77617510
Publikováno v:
European journal of gastroenterologyhepatology. 23(8)
BACKGROUND HFE hemochromatosis (HFE-H) is the most common and well-defined inherited cause for iron-related morbidity and mortality. Majority of patients with HFE-H are homozygote for C282Y mutation. Recent studies suggest that iron accumulation in m
Autor:
Arvind Sangwaiya, Jayantha Arnold, Caroline Kannengiesser, Mark Thursz, Vijay Manglam, Mark Busbridge, Caroline Beaumont
Publikováno v:
World journal of gastroenterology. 16(28)
AIM: To study the role of hepcidin in hereditary hyperferritinemia cataract syndrome (HHCS). METHODS: Six patients from two families with HHCS, confirmed by genetic analysis showing A to G mutation at position +40 in the L-ferritin gene, were recruit
Autor:
Vijay Manglam, Mark Thursz, Mark Busbridge, Frank Geoghegan, Jayantha Arnold, Arvind Sangwaiya
Publikováno v:
World journal of gastroenterology. 16(17)
AIM: To examine body fluids such as ascitic fluid (AF), saliva, bile and pleural effusions for the presence of hepcidin using a novel radioimmunoassay (RIA). METHODS: Serum samples were collected from 25 healthy volunteers (mean age: 36 ± 11.9 years
Publikováno v:
Gut. 60:A57-A57
Introduction Majority of patients with HFE hemochromatosis ( HFE -H) are homozygote for C282Y mutation. Studies suggest iron accumulation in most types of hemochromatosis is due to hepcidin deficiency. The precise link between hepcidin levels and iro